The RESPOND Outcomes Study

RecruitingOBSERVATIONAL
Enrollment

37,853

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
HIV
Trial Locations (18)

1000

RECRUITING

CHU Saint-Pierre Hospital, Brussels

1105

RECRUITING

The ATHENA (AIDS Therapy Evaluation in the Netherlands) national observational HIV cohort, Stichting HIV Monitorin, AMC, University of Amsterdam, Amsterdam

2052

RECRUITING

The Australian HIV Observational Database (AHOD), Sydney

2100

RECRUITING

Rigshospitalet, Copenhagen

RECRUITING

The EuroSIDA Study, CHIP, Rigshospitalet, Copenhagen

5093

RECRUITING

University Hospital Cologne, Cologne

6020

RECRUITING

Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruch, Innsbruck

8091

RECRUITING

Swiss HIV Cohort Study (SHCS), University Hospital Zurich, Zurich

20124

RECRUITING

Italian Cohort Naive Antiretrovirals (ICONA), Milan

44100

RECRUITING

Modena HIV Cohort, Università degli Studi di Modena, Modena

53105

RECRUITING

University Hospital Bonn, Bonn

60323

RECRUITING

Frankfurt HIV Cohort Study, Goethe-University Frankfurt, Frankfurt

Unknown

RECRUITING

Nice HIV Cohort, Centre Hospitalier Universitaire de Nice, Nice

RECRUITING

Georgian National AIDS Health Information System (AIDS HIS), IDACIRC, Tbilisi

RECRUITING

San Raffaele Scientific Institute, Ospedale San Raffaele, Milan

08916

RECRUITING

PISCIS Cohort Study, Germans Trias i Pujol University Hospital, Badalona

171 76

RECRUITING

Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm

NW3 2 PF

RECRUITING

Royal Free HIV Cohort Study, Royal Free Hospital, London

Sponsors
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

ViiV Healthcare

INDUSTRY

lead

Rigshospitalet, Denmark

OTHER